1h Free Analyst Time
The interventional oncology market is forecasted to grow by USD 1.03 bn during 2023-2028, accelerating at a CAGR of 7.7% during the forecast period. The report on the interventional oncology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase prevalence of cancer, growing demand for minimally-invasive surgical procedures, and growing focus on r and d activities in interventional oncology.
The interventional oncology market is segmented as below:
By End-user
- Hospitals and diagnostic centers
- Ambulatory surgery centers
- Research and academic institutes
By Product
- Particle embolization
- Ablation
- Support devices
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the interventional oncology market covers the following areas:
- Interventional oncology market sizing
- Interventional oncology market forecast
- Interventional oncology market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global interventional oncology market: AngioDynamics Inc., Becton Dickinson and Co., Boston Scientific Corp., Cook Group Inc., Elekta AB, HealthTronics Inc., Hologic Inc., IceCure Medical Ltd., INSIGHTEC Ltd., Johnson and Johnson, Medtronic Plc, MedWaves Inc., Merit Medical Systems Inc., Mermaid Medical Group, Profound Medical Corp., Siemens AG, Sirtex Medical Pty Ltd., Teleflex Inc., Terumo Corp., and Quantum Surgical SAS.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is growing focus on the adoption of MWA.'
According to the report, one of the major drivers for this market is the increase prevalence of cancer.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AngioDynamics Inc.
- Becton Dickinson and Co.
- Boston Scientific Corp.
- Cook Group Inc.
- Elekta AB
- HealthTronics Inc.
- Hologic Inc.
- IceCure Medical Ltd.
- INSIGHTEC Ltd.
- Johnson and Johnson
- Medtronic Plc
- MedWaves Inc.
- Merit Medical Systems Inc.
- Mermaid Medical Group
- Profound Medical Corp.
- Siemens AG
- Sirtex Medical Pty Ltd.
- Teleflex Inc.
- Terumo Corp.
- Quantum Surgical SAS
